Document is current
Any future updates will be listed below
-
Authors
Hautbergue, Guillaume M. https://orcid.org/0000-0002-1621-261X
Castelli, Lydia M.
Ferraiuolo, Laura
Sanchez-Martinez, Alvaro https://orcid.org/0000-0002-2728-6251
Cooper-Knock, Johnathan
Higginbottom, Adrian
Lin, Ya-Hui
Bauer, Claudia S.
Dodd, Jennifer E.
Myszczynska, Monika A.
Alam, Sarah M.
Garneret, Pierre
Chandran, Jayanth S.
Karyka, Evangelia
Stopford, Matthew J.
Smith, Emma F.
Kirby, Janine https://orcid.org/0000-0002-7468-5917
Meyer, Kathrin https://orcid.org/0000-0002-5052-2101
Kaspar, Brian K.
Isaacs, Adrian M.
El-Khamisy, Sherif F.
De Vos, Kurt J.
Ning, Ke
Azzouz, Mimoun
Whitworth, Alexander J. https://orcid.org/0000-0002-1154-6629
Shaw, Pamela J.
- License Information
-
More Information
Article History
Received: 4 December 2016
Accepted: 24 May 2017
First Online: 5 July 2017
Competing interests
: G.M.H., M.A., A.J.W. and P.J.S. have filed a patent application on the use of SRSF1 antagonists for the treatment of neurodegenerative disorders. The remaining authors declare no competing financial interests.
